Neisseria/HSV vaccine (Finlay Institute)

N/A

Report date: 2025/01/26 18:20:15

Base Information

Drug NameNeisseria/HSV vaccine (Finlay Institute)

Drug Alias NameAdjuvant Finlay Proteoliposome 1 derived cochleate/recombinant glycoprotein D vaccine (Finlay)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsReproductive Tract Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCuba

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFinlay Institute

China Registration ClassN/A

Develop Information

Active CompaniesFinlay Institute

Inactive CompaniesN/A

Active IndicationsReproductive Tract Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A